SOLV vs EXEL
Comparison between Solventum Corp (SOLV, Company) and Exelixis Inc (EXEL, Company).
Both SOLV and EXEL are from the Healthcare sector.
SOLV vs EXEL - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
SOLV
$12B
Winner
EXEL
$12B
Max Drawdown
Winner
SOLV
39.97%
EXEL
97.38%
Sharpe Ratio
SOLV
0.41
Winner
EXEL
0.74
5Y Beta
SOLV
0.86
Winner
EXEL
0.54
Industry
SOLV
Medical Instruments & Supplies
EXEL
Biotechnology
P/E Ratio
Winner
SOLV
8.60
EXEL
15.37
Forward P/E
Winner
SOLV
10.60
EXEL
14.43
PEG Ratio
Winner
SOLV
0.03
EXEL
0.40
5Y EPS CAGR
SOLV
N/A
EXEL
72.24%
Debt to Equity
SOLV
102.23%
Winner
EXEL
0.00%
Free Cash Flow Yield
SOLV
-1.65%
Winner
EXEL
7.43%
P/S Ratio
Winner
SOLV
1.49
EXEL
5.28
P/B Ratio
Winner
SOLV
2.32
EXEL
5.19
SOLV vs EXEL - Historical Returns
Returns include dividend reinvestment.
1M
Winner
SOLV
+12.44%
EXEL
+8.96%
3M
SOLV
-6.02%
Winner
EXEL
+9.58%
6M
SOLV
+2.59%
Winner
EXEL
+18.01%
1Y
SOLV
+10.12%
Winner
EXEL
+31.95%
5Y(CAGR)
SOLV
N/A
EXEL
+13.91%
10Y(CAGR)
SOLV
N/A
EXEL
+25.56%
Max(CAGR)
SOLV
-4.01%
Winner
EXEL
+4.65%
SOLV vs EXEL - Annual Returns (2000 - 2026)
Returns include dividend reinvestment.
| Year | SOLV | EXEL |
|---|---|---|
| 2026 | -7.15% | +10.51% |
| 2025 | +20.19% | +29.14% |
| 2024 | -17.43% | +39.16% |
| 2023 | N/A | +47.18% |
| 2022 | N/A | -16.37% |
| 2021 | N/A | -10.96% |
| 2020 | N/A | +13.65% |
| 2019 | N/A | -11.59% |
| 2018 | N/A | -37.36% |
| 2017 | N/A | +106.38% |
| 2016 | N/A | +171.58% |
| 2015 | N/A | +241.82% |
| 2014 | N/A | -76.70% |
| 2013 | N/A | +26.92% |
| 2012 | N/A | -1.93% |
| 2011 | N/A | -44.26% |
| 2010 | N/A | +9.47% |
| 2009 | N/A | +41.19% |
| 2008 | N/A | -42.56% |
| 2007 | N/A | -8.87% |
| 2006 | N/A | -7.60% |
| 2005 | N/A | +2.39% |
| 2004 | N/A | +35.71% |
| 2003 | N/A | -7.35% |
| 2002 | N/A | -49.40% |
| 2001 | N/A | +30.97% |
| 2000 | N/A | -0.81% |
SOLV vs EXEL Drawdown Comparison
The maximum drawdown for SOLV was -39.97%, occurring on Jul 9, 2024. Recovery took 229 trading sessions.
The maximum drawdown for EXEL was -97.38%, occurring on Dec 24, 2014. This drawdown has not yet recovered.
The current SOLV drawdown is -14.82%. The current EXEL drawdown is -2.21%.
| Rank | SOLV | EXEL |
|---|---|---|
| #1 | -39.97% Mar 26, 2024 - Feb 25, 2025 | -97.38% Jul 26, 2000 - Dec 24, 2014 |
| #2 | -27.46% Jan 9, 2026 - Apr 7, 2026 | -38.22% May 4, 2000 - Jun 5, 2000 |
| #3 | -25.02% Feb 26, 2025 - Nov 25, 2025 | -9.05% Jun 22, 2000 - Jun 28, 2000 |
| #4 | -7.87% Nov 25, 2025 - Jan 9, 2026 | -8.99% Jul 12, 2000 - Jul 24, 2000 |
| #5 | N/A | -8.50% Jun 7, 2000 - Jun 21, 2000 |
| #6 | N/A | -6.38% Jun 29, 2000 - Jul 6, 2000 |
| #7 | N/A | -2.41% Apr 20, 2000 - Apr 28, 2000 |
| #8 | N/A | -0.81% Apr 17, 2000 - Apr 19, 2000 |
Correlation
Correlation between SOLV and EXEL is 0.68 which considered as a moderate positive correlation - the stocks show some tendency to move together.
0.68
-101
Select Stocks to Compare
Popular: SOLV vs SPYEXEL vs SPY
More Comparisons
Compare with similar stocks